Romain Palich

41PUBLICATIONS
45CO-AUTHORS
Gene and molecular therapyPacific Peoples cultural determinants of healthPreventative health careRegenerative medicine (incl. stem cells)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Jul 14, 2026
Archived M184V/I Mutation and Risk of Virological Failure After Switching to Doravirine, Lamivudine, Tenofovir Disoproxil Fumarate: A National Observational Study (Dat'AIDS Cohort).

|Jul 08, 2026
Outcomes of Kaposi sarcoma in people living with HIV who maintain long-term viral suppression: A prospective case-series.

|Jun 08, 2026
High Uptake of HIV Pre-exposure Prophylaxis Among Men Who Have Sex with Men Recruited via Geosocial Networking Applications and Community Outreach in Paris, France.

|Feb 15, 2026
HBV reactivation after switching to cabotegravir plus rilpivirine therapy among people living with HIV: do not forget the reservoir.

Rémi Rouget, Sophie Seang, Marion Favier

|Jan 09, 2026
Switch to Bictegravir/Tenofovir Alafenamide/Emtrictabine or Dolutegravir + Tenofovir Disoproxil Fumarate/Emtrictabine in Virologically Suppressed People With HIV: Outcomes in Real-world Setting With and Without Tenofovir Resistance.

Alain Makinson, Firouze Bani-Sadr, Romain Palich

|Dec 16, 2025
Despite increasing use of integrase inhibitors to treat HIV infection, resistance to this class remains stable.

Cathia Soulie, Rachid Agher, Antoine Fauchois

Pageof 7

Frequent Collaborators

14 joint publications

Basma Abdi

8 joint publications

Marc Wirden

6 joint publications

Valérie Pourcher

5 joint publications

Lise Cuzin